MRC1 and sarcoma: In a sarcoma model, CD206+IL-4Rα+CD64+ macrophages were mainly found in progressively growing tumors and were reduced by immune checkpoint therapy, whereas iNOS+ macrophages were not found early on but were induced upon immune therapy [40].